Starting with a case from the UDP of a child with a neurodevelopmental disorder with a de novo variant of unknown significance in EBF3 (Early B-Cell Factor 3), the MOSC identified two additional patients with de novo variants altering the same amino acid of the EBF3 protein through collaborative database searches. Here, EBF3 is linked to neurodevelopmental disorder.